Examining Fidelity's structural growth approach and SharpeMetrix's data-driven alternative
MSCI EAFE Growth
40–80 Stocks
The Fidelity Advisor International Growth SMA seeks to invest in companies benefiting from multiyear structural growth tailwinds and high barriers to entry that are trading at attractive valuations based on Fidelity's earnings estimates. The strategy focuses on developed international markets through the EAFE universe.
While Fidelity's SMA offers quality active management, SharpeMetrix provides a systematic, rules-based approach powered by proprietary alternative data—at a flat fee that protects your margins.
Our proprietary signals analyze earnings expectations, sentiment, and innovation metrics—data not available in traditional SMAs.
Unlike traditional SMAs with asset-based fees, SharpeMetrix offers transparent flat-fee pricing that scales with your practice.
Rules-based portfolio construction eliminates manager risk and ensures consistent application of proven factors.
MSCI ACWI ex-USA | 40-80 Holdings
MSCI U.S. IMI Health Care 25/50 | 40-80 Holdings
Russell 1000 Growth | 40-80 Holdings
S&P 500 | 70-100 Holdings
Russell 2000 | 60-100 Holdings
Complete guide to SMAs vs TAMPs